$1.19
-4.0%Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Negative gross margin indicates the company is losing money on each saleโunsustainable long-term.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
QSI โข NASDAQ
| Quantum-Si incorporated Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
REVENUE | |||||||
2.4M | 3.1M | 1.1M | 0.0 | 0.0 | 0.0 | 0.0 | |
GROSS PROFIT | |||||||
(5.7M) | (1.5M) | (594K) | (0.0) | (0.0) | (0.0) | (0.0) | |
-3.3M | 1.6M | 488K | 0.0 | 0.0 | 0.0 | 0.0 | |
OPERATING INCOME | |||||||
(93.7M) | (110.2M) | (111.7M) | (123.8M) | (96.9M) | (36.7M) | (36.6M) | |
(44.8M) | (50.5M) | (44.6M) | (42.3M) | (50.3M) | (9.1M) | (8.5M) | |
(53.8M) | (59.6M) | (67M) | (72.1M) | (46.6M) | (27.6M) | (28.1M) | |
-97M | -108.6M | -111.2M | -123.8M | -96.9M | -36.7M | -36.6M | |
PRE-TAX INCOME | |||||||
(0.0) | (0.0) | (0.0) | (0.0) | (5K) | (9K) | (0.0) | |
9M | 0.0 | 0.0 | 0.0 | -5K | 79K | 0.0 | |
-4.8M | (0.0) | (0.0) | (9.5M) | (0.0) | -10K | (5K) | |
-4.2M | 7.6M | 15.2M | -8.6M | 1.9M | 78K | 828K | |
-101.3M | -101M | -96M | -132.4M | -95M | -36.6M | -35.8M | |
NET INCOME | |||||||
(58K) | (56K) | (0.0) | (0.0) | (0.0) | (0.0) | (5K) | |
-101.3M | -101M | -96M | -132.4M | -95M | -36.6M | -35.8M |
QSI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 15, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 01, 2026 | April 01, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 03, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 03, 2026 | March 03, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 29, 2025 | December 29, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 20, 2025 | November 19, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 05, 2025 | November 05, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 |
Continue your QSI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.